Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy and Safety of Oral CEP-701 for the Treatment of Patients With Advanced Multiple Myeloma
This study has been terminated.
Study NCT00242827   Information provided by Teva Pharmaceutical Industries

First Received on September 27, 2005.   Last Updated on August 22, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
Sponsors listed in this trial